ARA - American Renal Associates Holdings, Inc.

NYSE - Nasdaq Real Time Price. Currency in USD

American Renal Associates Holdings, Inc.

500 Cummings Center
Suite 6550
Beverly, MA 01915
United States

IndustryDiagnostics & Research
Full Time Employees4,692

Key Executives

NameTitlePayExercisedYear Born
Mr. Joseph A. CarlucciCo-Founder, CEO & Chairman1.64MN/A1954
Mr. Syed T. KamalFounder, Pres & Director1.37MN/A1953
Mr. Mark C. HerbersInterim CFO & Interim Chief Accounting OfficerN/AN/A1955
Dr. Don E. WilliamsonExec. VP & COON/AN/A1963
Mr. Richard Pacheco CFE, AVA, MBAVP of Admin.N/AN/AN/A
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


American Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. As of June 30, 2018, it owned and operated 233 dialysis clinics in partnership with 400 nephrologist partners treating approximately 16,000 patients in 26 states and the District of Columbia. The company was founded in 1999 and is headquartered in Beverly, Massachusetts.

Corporate Governance

American Renal Associates Holdings, Inc.’s ISS Governance QualityScore as of July 29, 2019 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder Rights: 6; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.